-
Views
-
Cite
Cite
Morton H. Maxwell, Beyond Blood Pressure Control: Effect of Antihypertensive Therapy on Cardiovascular Risk Factors, American Journal of Hypertension, Volume 1, Issue 4_Pt_2, October 1988, Pages 366S–371S, https://doi.org/10.1093/ajh/1.4.366S
- Share Icon Share
Abstract
Mild hypertension accounts for approximately 60% of the mortality associated with high blood pressure. In addition to hypertension, other major cardiovascular risk factors include left ventricular hypertrophy (LVH), dyslipoproteinemia, and glucose intolerance. Thus, the effects of agents used to treat hypertension on these risk factors are of considerable importance. Large therapeutic intervention trials have shown that while adequate treatment of mild hypertension significantly and consistently reduces all-cause mortality as well as the risk of stroke and congestive heart failure, an anticipated reduction in coronary heart disease (CHD) has not been demonstrated. It is possible adverse metabolic side effects (hypercholesterolemia, hyperglycemia, hypokalemia) of widely used agents, such as diuretics and β-blockers may be partially offsetting the beneficial effects of blood pressure reduction, with the net result being a failure of these agents to reduce the risk of CHD. Angiotensin-converting enzyme inhibitors (ACEIs) and calcium channel blockers do not produce these adverse metabolic derangements. The use of antihypertensive agents that have favorable or neutral metabolic effects should further reduce the risk of cardiovascular morbidity and mortality attributable to high blood pressure, including CHD. Am J Hypertens 1988:1:366S-371S
- angiotensin-converting enzyme inhibitors
- antihypertensive agents
- dyslipidemias
- calcium channel blockers
- diuretics
- hypertension
- hypercholesterolemia
- hyperglycemia
- hypokalemia
- heart disease risk factors
- congestive heart failure
- left ventricular hypertrophy
- blood pressure
- glucose intolerance
- cardiovascular system
- morbidity
- mortality
- coronary heart disease
- antihypertensive therapy
- risk reduction
- blood pressure regulation
- therapeutic intervention
- stroke risk
- hypertension, mild
- metabolic side effects